Replies to post #177 on Enterologics Inc. (fka ELGO)

[moneymaker168]

And here another one. the corporate website is up

Enterologics, Inc. Launches Corporate Website www.enterologics.com


Press Release Source: Enterologics, Inc. On Tuesday April 26, 2011, 4:45 pm EDT

SAINT PAUL, MN--(Marketwire - 04/26/11) - Enterologics, Inc. (OTC.BB:ELGO - News), a biotechnology company, today announced the launch of www.enterologics.com. The website provides information about the Company, as well as information about probiotics and their potential role for treating individuals with gastrointestinal (GI) disorders.

The Company recently announced its business strategy to develop unique probiotic strains as biologic drugs for GI conditions with unmet therapeutic needs, such as pouchitis, irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis and Clostridium difficile infections. President and Co-Founder Bob Hoerr stated, "We believe that broader medical use of probiotics will follow convincing clinical tests of the type used to obtain regulatory approval for drugs and biologics. Enterologics' development program is designed to bring clinically useful probiotic products to market. This means producing each product in a dosage formulation with predictable potency and showing that the product provides meaningful outcomes in clinical trials."

Enterologics, Inc. (OTC.BB:ELGO - News) is a biotechnology company that is developing probiotics as biologic drugs for specific gastrointestinal disease indications. Probiotics are live microorganisms, in most cases, bacteria, that are similar to or derived from beneficial microorganisms that are found in the human gut (e.g. for more information see Introduction to Probiotics). They are also called "friendly bacteria" or "good bacteria." Enterologics intends to identify, in-license and develop unique probiotic strains for specific medical conditions, obtain regulatory approval and market these probiotics products as FDA-approved prescription drugs for specific label indications. More details about Enterologics' business and its technology and product focus are available at www.enterologics.com. The website will also provide updates about the Company's progress in developing products that address unmet therapeutic needs for gastrointestinal diseases.